参附注射液急重症临床应用专家共识

doi:10.3969/j.issn.1002-1949.2018.11.001

摘要
图/表
参考文献(60)
相关文章 (8)

全文: PDF (1039 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要参附注射液是由红参、附片提取制成的中药注射剂，1987年获得上市许可，应用于临床已经有30余年历史，广泛应用于休克、心肺复苏、心力衰竭等急危重症，列为《国家基本医疗保险、工伤保险和生育保险药品目录》甲类品种。上市后再评价研究表明，参附注射液安全性高，并且具有良好的卫生经济学效益。因此，参附注射液被《中国严重脓毒症/脓毒性休克治疗指南》、《心肺复苏与中西医结合急救指南》、《急性心肌梗死中医临床诊疗指南》、《慢性心力衰竭中西医结合诊疗专家共识》等多个国内指南和共识推荐，是临床治疗急危重症必备的中成药。为了促进参附注射液在临床上的合理使用，并运用新的循证医学证据指导临床用药，中国医师协会急诊医师分会和中国研究型医院学会休克与脓毒症专业委员会组织多位有相关经验的临床专家，对参附注射液在急重症临床应用的循证医学证据进行广泛的讨论，共同起草和制定了《参附注射液急重症临床应用专家共识》（以下简称《共识》），以供临床医师、药师在临床工作中参考。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	中国医师协会急诊医师分会
	中国研究型医院学会休克与脓毒症专业委员会

关键词 ：参附注射液, 急重症, 专家共识

引用本文:

中国医师协会急诊医师分会，中国研究型医院学会休克与脓毒症专业委员会. 参附注射液急重症临床应用专家共识[J]. 中国急救医学, 2018, 38(11): 925-931.

链接本文:

http://www.cnemergency.org.cn/CN/10.3969/j.issn.1002-1949.2018.11.001 或 http://www.cnemergency.org.cn/CN/Y2018/V38/I11/925

［1］Shiffman RN, Shekelle P, Overhage JM, et al. Standardized reporting of clinical practice guidelines: a proposal from the conference on guideline standardization［J］. Ann Intern Med, 2003, 139(6): 493-498. ［2］Guyatt GH, Oxman AD, Vist GE, et al. Rating Quality of evidence and strength of recommendations: gRADE: an emerging consensus on rating quality of evidence and strength of cecommendations［J］. Chinese Journal of Evidence-Based Medicine, 2008, 336(7650): 924-926.  ［3］Yang H, Liu L, Gao W, et al. Direct and comprehensive analysis of ginsenosides and diterpene alkaloids in Shenfu injection by combinatory liquid chromatography-mass spectrometric techniques［J］. J Pharm Biomed Anal, 2014, 92: 13-21.  ［4］Song Y, Zhang N, Jiang Y, et al. Simultaneous determination of aconite alkaloids and ginsenosides using online solid phase extraction hyphenated with polarity switching ultra-high performance liquid chromatography coupled with tandem mass spectrometry［J］. RSC Advances, 2015, 5(9): 6419-6428. ［5］何家乐，周思思，马增春，等. 基于UPLC-Q-TOF/MS研究参附注射液的物质基础［J］. 中国药理学通报， 2014， 30(3)：133-137. ［6］Zhang Y, Tian D, Huang Y, et al. Pharmacokinetic evaluation of Shenfu injection in Beagle dogs after intravenous drip administration［J］. Acta Pharmaceutica Sinica B(Engl), 2016, 6(6): 584-592.  ［7］Ni J, Shi Y, Li L, et al. Cardioprotection against heart failure by Shenfu injection via TGF-β/Smads signaling pathway［J］. Evidence-Based Complementray and Alternative Medicine, 2017, 2017(1): 7083016. ［8］叶淑萍. 参附注射液治疗急性心力衰竭疗效观察［J］. 现代中西医结合杂志，2016, 25(13): 1449-1451.  ［9］Ji XF, Ji HB, Sang DY, et al. Shen-Fu injection reduces impaired myocardial β-adrenergic receptor signaling after cardiopulmonary resuscitation.［J］. Chin Med J (Engl), 2013, 126(4): 697. ［10］Ji XF, Yang L, Zhang MY, et al. Shen-fu injection attenuates postresuscitation myocardial dysfunction in a porcine model of cardiac arrest［J］. Shock, 2011, 35(5): 530-536.  ［11］王正荣，杨芳炬，徐彬，等. 参附注射液对大鼠肠系膜微循环的作用［J］. 中药药理与临床， 2001， 17(4)： 8-9. ［12］Wu J, Li C, Yuan W. Effects of Shenfu injection on macrocirculation and microcirculation during cardiopulmonary resuscitation［J］. J Ethnopharmacol, 2016, 180: 97-103. ［13］Wu Y, Xia ZY, Meng QT, et al. Shen-Fu injection preconditioning inhibits myocardial ischemia-reperfusion injury in diabetic rats: activation of eNOS via the PI3K/Akt pathway［J］. J Biomed Biotechnol, 2011, 2011: 384627.  ［14］Fen-fang H, Fa-xian G, Ying Z, et al. Shenfu injection protects human ECV304 cells from hydrogen peroxide via its anti-apoptosis way［J］. J Ethnopharmacol, 2015, 163: 203-209.  ［15］Gu W, Li C, Yin W, et al. Shen-fu injection reduces postresuscitation myocardial dysfunction in a porcine model of cardiac arrest by modulating apoptosis.［J］. Shock, 2012, 38(3): 301-306. ［16］Wang YL, Wang CY, Zhang BJ, et al. Shenfu injection suppresses apoptosis by regulation of Bcl-2 and caspase-3 during hypoxia/reoxygenation in neonatal rat cardiomyocytes in vitro［J］. Molecular Biology Reports, 2009, 36(2): 365-370. ［17］张晓膺，郑世营，赵军，等. 参附注射液对缺氧心肌细胞凋亡的抑制效应［J］. 江苏医药, 2005， 31(2): 113-115.  ［18］Qian Zhang, Chun-sheng Li, Shuo Wang, et al. Effects of Chinese Medicine Shen-Fu Injection on the expression of inflammatory cytokines and complements during post-resuscitation immune dysfunction in a porcine model［J］. Chin J Integr Med, 2016, 22(2): 101-109. ［19］JIN Yan-yan, GAO Hai, ZHANG Xin-yong, et al. Shenfu injection inhibits inflammation in patients with acute myocardial infarction complicated by cardiac shock［J］. Chin J Integr Med, 2017, 23(3): 170-175.  ［20］Cao J, Zheng CD, Zhang GX, et al. Protective effect of Shenfu injection on myocardial mitochondria injured by ischemia-reperfusion in rabbits［J］. Chin Med J (Engl), 2005, 118(6):505-507. ［21］Shu-Yun Zheng, Jie Sun, Xin Zhao, et al. Protective Effect of Shen-Fu on Myocardial Ischemia-Reperfusion Injury in Rats［J］. American Journal of Chinese Medicine, 2004, 32(2):209. ［22］Guo ZJ, Wu CJ, Li CS. Shen-fu Injection, alleviates post-resuscitation myocardial dysfunction by up-regulating expression of sarcoplasmic reticulum Ca(2+)-ATPase［J］. Chin J Integr Med, 2016, 22(7): 503-509. ［23］Zhang H, Wan Z, Yan X, et al. Protective effect of Shenfu injection preconditioning on lung ischemia-reperfusion injury［J］. Exp Ther Med, 2016, 12(3): 1663-1670.  ［24］Chen T, Cheng M, Yuan Z, et al. Protective role of Shenfu on ischemia-reperfusion injury of rat liver grafts［J］. Transplant Proc, 2012, 44(4): 978-981.  ［25］Zhu WH. Effect of Shenfu injection on ischemia-reperfusion injury of rat liver graft［J］. Hepatobiliary Pancreat Dis Int), 2006, 5(2): 205.  ［26］李爱华，李倩，白桂春，等. 参附注射液预处理对大鼠急性脑缺血再灌注损伤的保护作用［J］. 中成药，2015, 37(8): 1818-1820.  ［27］杨勇，任长虹，吴晓丹. 参附注射液对大鼠局灶性脑缺血再灌注损伤的保护作用及其机制研究［J］. 天津中医药， 2014， 31(7): 436-439.  ［28］Yang LJ, Wang J, Tian ZF, et al. Shenfu injection attenuates neonatal hypoxic-ischemic brain damage in rat［J］. Neurol Sci, 2013, 34(9): 1571-1574.  ［29］Hou X, Li C, Gu W, et al. Effect of Shenfu on inflammatory cytokine release and brain edema after prolonged cardiac arrest in the swine［J］. Am J Emerg Med, 2013, 31(8): 1159-1164.  ［30］Gu W, Hou X, Zhou H, et al. Protective effect of Shen-Fu injection on neuronal mitochondrial function in a porcine model of prolonged cardiac arrest［J］. Evid Based Complement Alternat Med, 2014, 2014: 523847.  ［31］Zhang Y, Li CS, Wu CJ, et al. Neuroprotective effect of Shenfu injection, following cardiac arrest in pig correlates with improved mitochondrial function and cerebral glucose uptake［J］. Chin J Integr Med, 2014, 20(11): 835.  ［32］Zhang MY, Ji XF, Wang S, et al. Shen-fu injection attenuates postresuscitation lung injury in a porcine model of cardiac arrest［J］. Resuscitation, 2012, 83(9): 1152-1158.  ［33］Gu W, Li CS, Yin WP, et al. Effects of Shen-Fu injection on the expression of T-cell specific transcription factors T-bet / GATA-3 in porcine postresuscitation lung injury［C］// 2012北京医学会急诊医学分会学术年会, 2012: 464650. ［34］Zhang N, Liu J, Qiu Z, et al. Shenfu injection for improving cellular immunity and clinical outcome in patients with sepsis or septic shock［J］. Am J Emerg Med, 2017, 35(1): 1-6.  ［35］邓永诚，董丽军. 参附注射液对心力衰竭患者心功能及血浆脑钠肽水平的影响［J］. 中华危重症医学杂志:电子版， 2010， 3(5): 17-19.  ［36］Song WT, Cheng FF, Xu L, et al. Chinese Medicine Shenfu Injection for Heart Failure: A Systematic Review and Meta-Analysis［J］. Evid Based Complement Alternat Med, 2012, 2012(1): 713149.  ［37］杜浩，戴小华. 参附注射液治疗心力衰竭的Meta分析［J］. 中华中医药杂志, 2014， 11: 3643-3646.  ［38］何志红. 参附注射液辅助治疗急性心衰的效果及对TIMP-1、MMP-3的影响［J］. 中国医药导报， 2016， 13(31)：105-108. ［39］胡元会，吴华芹，祁鑫，等. 参附注射液对冠心病慢性心力衰竭患者心功能及骨髓干细胞动员的影响［J］. 中国中西医结合杂志， 2009， 29(4)： 309-312. ［40］毕晓锋，刘国斌. 参附注射液治疗心源性休克的疗效观察［J］. 实用临床医学， 2005， 6(9)： 32-34.  ［41］杨倩春，毛炜，刘旭生，等. 参附注射液治疗心源性休克有效性和安全性系统评价［J］. 中华中医药杂志， 2012， 4：1052-1059.  ［42］张熹煜，钟敏莹. 参附注射液联合主动脉内球囊反搏术治疗心源性休克临床观察［J］. 新中医， 2010， 9： 18-19. ［43］田继文. 参附注射液联合主动脉内球囊反搏术治疗心源性休克［J］. 长春中医药大学学报， 2014， 30(5)： 884-886. ［44］严华，胡正清，徐广. 参附注射液对急性心肌梗死早期患者左室重塑及心功能的影响［J］.现代中西医结合杂志，2017，26(1)：52-54. ［45］尤华彦. 参附注射液对急诊PCI术后患者梗死面积及心功能的影响［J］. 中国中医急症， 2009， 18(9)： 1441-1442.  ［46］卢琼，杨华. 参附注射液对肺心病急性期患者血液流变学影响［J］. 世界中医药, 2014， 10： 1310-1312.  ［47］辛凤志. 参附注射液对慢性肺源性心脏病患者心肺功能和运动耐力的改善作用［J］. 中国医药导报, 2007， 4(17)： 84-85. ［48］周鑫斌，缪静，庄钦，等. 参附注射液辅助治疗冠心病心绞痛疗效的Meta分析［J］. 中国中药杂志，2016， 41(3)： 536-540.  ［49］马敬，郭建华，叶玮. 参附注射液在心脏手术中心肌保护作用的荟萃分析［J］. 中国药物评价, 2015， 3： 167-171.  ［50］Mo Y, Liu X, Qin X, et al. Shenfu injection for intradialytic hypotension: a systematic review and meta-analysis［J］. Evid Based Complement Alternat Med, 2014, 2014: 279 853. ［51］任德权，张伯礼，翁维良，等. 中药注射剂临床应用指南［M］. 2011： 157-160. ［52］Mou Z, Lv Z, Li Y, et al. Clinical effect of Shenfu injection in patients with septic shock: a meta-analysis and systematic review［J］. Evid Based Complement Alternat Med, 2015, 2015: 863149.  ［53］Li Y, Zhang X, Lin P, et al. Effects of Shenfu injection in the treatment of septic shock patients: a multicenter, controlled, randomized, open-label trial［J］. Evid Based Complement Alternat Med, 2016, 2016: 2 565 169. ［54］Zhang Q, Li C, Shao F, et al. Efficacy and safety of combination therapy of Shenfu injection and postresuscitation bundle in patients with return of spontaneous circulation after in-hospital cardiac arrest: a randomized, assessor-blinded, controlled trial［J］. Crit Care Med, 2017, 45(10): 1587-1595. ［55］陈德俊，林悦涛，陈奕彬. 参附注射液治疗急性心肌梗死患者经皮冠状动脉介入治疗后低血压状态的临床研究［J］. 岭南心血管病杂志， 2015， 21(6)：770-774.  ［56］邱泽亮，叶一萍，张宁，等. 参附注射液治疗严重脓毒症临床疗效及对血清IL-6、IL-10水平的影响［J］. 中国中西医结合杂志， 2012， 32(3)： 348-351. ［57］丁良才，刘雪峰，何超，等. 参附注射液对ARDS患者肺血流量及呼吸力学影响的研究［J］. 中国中医急症， 2010， 19(5)： 774-775.  ［58］张茜利，马玉海，叶和军. 参附注射液对慢性阻塞性肺疾病急性加重期患者临床疗效和作用机制研究［J］. 辽宁中医杂志， 2014， 7： 1446-1448.  ［59］王志飞，喻锦扬，谢雁鸣. 参附注射液30106例上市后临床安全性医院集中监测［J］. 中国中药杂志， 2017， 42(15)：2871-2876. ［60］李倩, 周挺, 官海静,等. 参附注射液联合常规方案治疗心力衰竭的成本效果分析［J］. 中国新药杂志， 2017， 14：1718-1724.